Key Growth Parameters

Definitions of Key Growth and Development Parameters

The term growth denotes a net increase in the physical size or mass of tissues within the body.
It is primarily attributed to the multiplication of cells (hyperplasia) and the increase in intracellular substance, with the expansion of cell size (hypertrophy) contributing to a lesser extent.
Growth is a continuous and orderly process, characterized by a unique pattern for every individual, generally proceeding in a cephalocaudal and distal-to-proximal direction.

Development specifies the maturation of physiological and cognitive functions.
It is intricately related to the progressive maturation and myelination of the central nervous system.
The process indicates the acquisition of various skills necessary for an individual’s optimal functioning, manifesting as specific milestones (e.g., turning over, reaching for objects, speaking).

Growth velocity represents the rate of increase in a specific growth parameter over a defined period of time, most commonly expressed for height as centimeters per year (cm/year).
Plotting growth velocity sequentially provides a highly valuable tool for the early identification of factors affecting growth and helps predict the ultimate adult height more accurately than a single measurement.
The average height velocity dynamically changes: it is roughly 25 cm/year in the first year of life, declines to 4–6 cm/year in prepubertal children, and accelerates again during the pubertal growth spurt to a peak of 8–12 cm/year.

Mean: The mean represents the mathematical average value of a specific parameter in a population that follows a typical Gaussian (normal) distribution. Measurements are often expressed as standard deviation scores (SDS) or z-scores to denote how many standard deviations an individual's value lies above or below this population mean.
Median: The median is the 50th percentile curve on a growth chart, also termed the standard value. It signifies the exact midpoint of a population's distribution, where half of the individuals fall above this measurement and half fall below.
Percentiles: Percentile curves represent the frequency distribution of a measured quantity within a specific group or population. For instance, a child whose height falls on the 25th percentile indicates that 25% of individuals in the reference population are shorter than this value, while 75% are taller.

Retarded growth (short stature) is statistically defined as a height below the 3rd centile or more than two standard deviation scores (<-2 SDS) below the median height for a given age and gender.
Children whose stature falls below -3 SDS are highly likely to have a pathological etiology, whereas those between -2 and -3 SDS more frequently represent normal physiological variants.

Category	Specific Etiologies
Physiological / Normal Variants	Familial short stature, Constitutional growth delay.
Undernutrition	Chronic protein-energy malnutrition, inadequate dietary intake.
Chronic Systemic Illnesses	Cerebral palsy, congenital heart disease, cystic fibrosis, asthma.
Malabsorption / GI Disorders	Celiac disease, chronic liver disease, chronic diarrhea.
Endocrine Causes	Growth hormone (GH) deficiency or insensitivity, hypothyroidism, Cushing syndrome, pseudohypoparathyroidism, precocious or delayed puberty.
Genetic / Chromosomal Syndromes	Turner syndrome, Down syndrome, Prader-Willi syndrome, Russell-Silver syndrome, Seckel syndrome.
Skeletal Dysplasias	Achondroplasia, hypochondroplasia (abnormal skeletal proportions).
Other Pathological Causes	Rickets, psychosocial dwarfism (emotional deprivation), small for gestational age (SGA) with inadequate catch-up growth, idiopathic short stature (ISS).

A comprehensive clinical schedule begins with a meticulously detailed medical, developmental, and family history.
The history must screen for clues such as low birth weight (suggesting SGA), polyuria (suggesting renal tubular acidosis), chronic diarrhea (suggesting malabsorption), or a family history of delayed puberty (suggesting constitutional delay).
The physical examination should assess body proportions (Upper Segment:Lower Segment ratio and arm span) to rule out skeletal dysplasias, and look for dysmorphism, pallor, goiter, central obesity, or signs of rickets.
Height should be accurately measured using an infantometer (for children <2 years) or a stadiometer (for children >2 years) and plotted on appropriate growth charts to calculate height velocity and compare it against the mid-parental height (genetic potential).

Bone Age Assessment: A radiograph of the left hand and wrist should be performed in all children presenting with short stature to determine skeletal maturity.
Bone age helps differentiate between etiologies: it equals chronological age in familial short stature, but is delayed (less than chronological age) in constitutional delay, hypothyroidism, and GH deficiency.
Skeletal Survey: If the child presents with disproportionate short stature, a full skeletal survey (skull, thoracolumbar spine, chest, pelvis, and limbs) is required to rule out rickets or specific skeletal dysplasias.

Investigation Tier	Specific Tests & Rationale
Level 1 (Essential Screening)	Complete Hemogram with ESR: To rule out chronic anemia and chronic infections.Urinalysis: Including microscopy, osmolality, and pH to screen for chronic kidney disease or renal tubular acidosis.Stool Examination: For parasites, steatorrhea, and occult blood to assess for malabsorption.Serum Biochemistry: Blood urea, creatinine, bicarbonate, pH, calcium, phosphate, alkaline phosphatase, fasting glucose, albumin, and transaminases to comprehensively evaluate renal, hepatic, and bone health.
Level 2 (Targeted Evaluation)	Endocrine Profile: Serum thyroxine (T4) and Thyroid Stimulating Hormone (TSH) to rule out occult hypothyroidism.Genetic Testing: Karyotype (or Chromosomal Microarray) in all girls with unexplained short stature to definitely rule out Turner syndrome, even in the absence of classic dysmorphic features.Gastrointestinal: Celiac serology.
Level 3 (Specialized Testing)	GH-IGF Axis Evaluation: Serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) levels.Provocative Testing: Provocative growth hormone testing if baseline markers suggest deficiency.Neuroimaging: MRI of the brain (specifically focusing on the pituitary and hypothalamus) if the peak growth hormone level is low, to rule out structural anomalies or space-occupying lesions like craniopharyngiomas.